New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
December 17, 2012
19:59 EDTRHHBYRoche ovarian cancer drug Avastin denied U.K. regulator support, Bloomberg says
Roche's (RHHBY) Avastin, an anti-tumor drug, did not receive the support of the U.K.'s National Institute for Health and Clinical Excellence, with the Institute citing the recommended dose as making it difficult to make clear how effective the medication is, according to a Bloomberg report that cites an e-mailed statement from the Institute. Reference Link
News For RHHBY From The Last 14 Days
Check below for free stories on RHHBY the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
May 22, 2013
10:33 EDTRHHBYBristol-Myers jumps after Citi ups rating on cancer potential
Subscribe for More Information
10:00 EDTRHHBYOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
06:02 EDTRHHBYRoche upgraded to Buy from Neutral at Citigroup
Subscribe for More Information
May 21, 2013
20:03 EDTRHHBYRoche, Sigma-Aldrich teamed for Life bid, Reuters says
Subscribe for More Information
May 20, 2013
17:26 EDTRHHBYRegeneron, Genentech, Sanofi enter into 'Zaltrap agreement'
Subscribe for More Information
17:20 EDTRHHBYRegeneron,, Bayer, Genentech resolve certain patent disputes
Subscribe for More Information
May 15, 2013
15:59 EDTRHHBYRoche exploring sale of blood glucose meters unit, Reuters says
Subscribe for More Information
12:13 EDTRHHBYRoche management to meet with Jefferies
Meeting to be held in London on May 17 hosted by Jefferies.
11:38 EDTRHHBYRoche says FDA approves Tarceva tablets for specific lung cancer situation
Subscribe for More Information
May 14, 2013
16:55 EDTRHHBYFDA approves Roche's cobas EGFR mutation test with Tarceva
Subscribe for More Information
May 13, 2013
08:55 EDTRHHBYBiosimiliar drug bill to be taken up in Senate, LA Times reports
Subscribe for More Information
07:30 EDTRHHBYTechConnect to host a summit
2013 National Innovation Summit is being held in Washington, D.C. on May 12-16.
May 10, 2013
15:59 EDTRHHBYRoche spokesman reiterates that Illumina is "off the table," Bloomberg reports
Subscribe for More Information
11:48 EDTRHHBYDrugmakers to face pressure on U.S. prices, Reuters says
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.